Screening & Discovery Services


Ideal for screening of compound and gene libraries, Glauconix BiosciencesTM tissue models and testing platforms can help companies accelerate results and save money to assess the efficacy of drug-like molecules during the hit-to-lead or lead-optimization stage, to triage lead compounds.  Its tissue models can also be utilized to discover and evaluate the up- or down-regulation of the target proteins or receptors of interest.